IDiyas

For the Inventor, By the Inventor

Radnor, PA, United States of America

Brian W Metcalf

USPTO Granted Patents = 19 

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 250(Granted Patents)


Location History:

  • Philadelphia, PA (US) (1992)
  • Radnor, PA (US) (1989 - 2000)

Company Filing History:

goldMedal14 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal4 out of 207 
 
Smithkline Beckman Corporation
 patents
bronzeMedal1 out of 832,680 
Other
 patents

Years Active: 1989-2000

Loading Chart...
19 patents (USPTO):Explore Patents
1. 6028087 - Platelet aggregation inhibiting compounds (2000-02-22),
2. 5726192 - Platelet aggregation inhibiting compounds (1998-03-10),
3. 5665753 - Cytokine inhibiting imidazole substituted hydroxamic acid derivatives (1997-09-09),
4. 5237065 - Steroid 5-alpha-reductase inhibitors (1993-08-17),
5. 5137882 - Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors (1992-08-11),
6. 5110939 - Intermediates in the preparation of steriod 5-alpha-reductase inhibitors (1992-05-05),
7. 5041433 - 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod (1991-08-20),
8. 5032586 - 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha (1991-07-16),
9. 5026882 - Phosphinic acid substituted steroids as inhibitors of steroid (1991-06-25),
10. 5023250 - Steroidal 14.alpha.-carboxy-alkyl derivatives as regulators of HMG-COA (1991-06-11),
11. 5017568 - Steriod 5-alpha-reductase inhibitors (1991-05-21),
12. 4970205 - Sulfonic acid substituted aromatic steroids as inhibitors of steroid (1990-11-13),
13. 4970204 - 3-substituted nitro-steroid derivatives as 5-.alpha.-reductase inhibitors (1990-11-13),
14. 4954446 - Aromatic steroid 5-.alpha.-reductase inhibitors (1990-09-04),
15. 4946834 - Phosphonic acid substituted steroids as steroid 5.alpha.-reductase (1990-08-07),

Title: Brian W. Metcalf: Innovator in Platelet Aggregation Inhibiting Compounds

Introduction: Brian W. Metcalf, based in Radnor, PA, is a prolific inventor known for his significant contributions to the field of medical innovations, particularly in platelet aggregation inhibitors. With a total of 19 patents to his name, he has made remarkable strides in developing compounds that hold potential in therapeutic applications.

Latest Patents: Among his latest breakthroughs are advanced platelet aggregation inhibiting compounds, specifically those characterized by unique formulas. These innovations aim to improve treatments for various medical conditions linked to platelet aggregation, showcasing his commitment to enhancing healthcare through scientific advancements.

Career Highlights: Brian W. Metcalf's career has been marked by tenure at prestigious organizations, including SmithKline Beecham Corporation and SmithKline Beckman Corporation. His work at these companies has allowed him to merge research with practical applications, ultimately leading to the successful development of several patentable inventions.

Collaborations: Throughout his career, Metcalf has collaborated with notable scientists such as Dennis Alan Holt and Mark A. Levy. These partnerships have fostered an environment of innovation, enabling the exchange of ideas and expertise that have propelled his research forward.

Conclusion: Brian W. Metcalf remains a key figure in the realm of medical research and innovation. His dedication to exploring new compounds and therapies continues to inspire advancements in the field, leaving an indelible mark on the world of inventions related to health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…